Trials / Completed
CompletedNCT02175693
Post-marketing Surveillance of Administration of Botulinum Toxin Type B(NerBloc)-Investigation of the Clinical Condition and Safety in Patients With Cervical Dystonia
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,647 (actual)
- Sponsor
- Eisai Co., Ltd. · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Investigation of the clinical condition and safety in patients with cervical dystonia
Conditions
Timeline
- Start date
- 2013-04-02
- Primary completion
- 2019-06-30
- Completion
- 2019-06-30
- First posted
- 2014-06-26
- Last updated
- 2020-01-09
Locations
2 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT02175693. Inclusion in this directory is not an endorsement.